BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
0.705
-0.021 (-2.83%)
At close: Nov 6, 2024, 4:00 PM
0.710
+0.005 (0.71%)
After-hours: Nov 6, 2024, 6:57 PM EST
BriaCell Therapeutics Employees
BriaCell Therapeutics had 16 employees as of July 31, 2023. The number of employees increased by 10 or 166.67% compared to the previous year.
Employees
16
Change
10
Growth
166.67%
Revenue / Employee
n/a
Profits / Employee
-$299,467
Market Cap
25.61M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jul 31, 2023 | 16 | 10 | 166.67% |
| Jul 31, 2021 | 6 | 0 | - |
| Aug 1, 2019 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Burning Rock Biotech | 786 |
| Bionano Genomics | 344 |
| ImmuCell | 79 |
| Spectral AI | 78 |
| Enlivex Therapeutics | 71 |
| IGC Pharma | 67 |
| NeuroOne Medical Technologies | 16 |
| Nexalin Technology | 6 |
BCTX News
- 2 days ago - BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13 - GlobeNewsWire
- 15 days ago - BriaCell Therapeutics: High-Potential In Phase 3 Metastatic Breast Cancer, But Financing Concerns - Seeking Alpha
- 15 days ago - BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data - GlobeNewsWire
- 22 days ago - BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study - GlobeNewsWire
- 5 weeks ago - BriaCell Therapeutics Announces Closing of $5 Million Offering - GlobeNewsWire
- 5 weeks ago - BriaCell Therapeutics Announces $5 Million Offering - GlobeNewsWire
- 5 weeks ago - BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” Tumor - GlobeNewsWire
- 7 weeks ago - BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients - GlobeNewsWire